ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,510,000 shares, a growth of 214.2% from the February 28th total of 798,900 shares. Currently, 26.8% of the company’s stock are sold short. Based on an average daily trading volume, of 2,450,000 shares, the short-interest ratio is presently 1.0 days.
ReWalk Robotics Stock Up 2.7 %
Shares of LFWD traded up $0.05 during mid-day trading on Thursday, hitting $1.88. 159,085 shares of the company traded hands, compared to its average volume of 665,236. ReWalk Robotics has a 1-year low of $1.25 and a 1-year high of $6.00. The company has a market capitalization of $19.98 million, a PE ratio of -0.75 and a beta of 1.73. The business has a 50 day moving average of $1.67 and a 200 day moving average of $2.10.
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last posted its quarterly earnings results on Friday, March 7th. The company reported ($1.73) EPS for the quarter, missing the consensus estimate of ($0.20) by ($1.53). The business had revenue of $7.55 million during the quarter, compared to analysts’ expectations of $7.30 million. ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. As a group, research analysts expect that ReWalk Robotics will post -1.78 EPS for the current fiscal year.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on LFWD
Insider Buying and Selling
In related news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the firm’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the completion of the sale, the insider now owns 1,049,430 shares of the company’s stock, valued at $3,526,084.80. This trade represents a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.50% of the stock is currently owned by company insiders.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Articles
- Five stocks we like better than ReWalk Robotics
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- What is Put Option Volume?
- Top 3 Beverage Stocks Pouring Out Profits
- What Makes a Stock a Good Dividend Stock?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.